Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

PCSA

Processa Pharmaceuticals (PCSA)

Processa Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PCSA
DateTimeSourceHeadlineSymbolCompany
11/05/202406:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
06/05/202422:00GlobeNewswire Inc.Processa Pharmaceuticals to Participate in the EF Hutton Annual Global ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/04/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical ResearchNASDAQ:PCSAProcessa Pharmaceuticals Inc
11/04/202422:00GlobeNewswire Inc.Processa Pharmaceuticals Presents Two Abstracts at the AACR Annual Meeting 2024 Including New Data on the NGC-Cap Phase 1b TrialNASDAQ:PCSAProcessa Pharmaceuticals Inc
28/03/202423:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
25/03/202423:15GlobeNewswire Inc.Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual MeetingNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/02/202409:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
22/02/202400:15GlobeNewswire Inc.Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
15/02/202405:00GlobeNewswire Inc.Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual ConferenceNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/02/202400:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
07/02/202400:30GlobeNewswire Inc.Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price RuleNASDAQ:PCSAProcessa Pharmaceuticals Inc
02/02/202410:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
02/02/202408:22GlobeNewswire Inc.Processa Pharmaceuticals Announces Closing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
01/02/202408:37Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PCSAProcessa Pharmaceuticals Inc
31/01/202402:46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
30/01/202408:15Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:PCSAProcessa Pharmaceuticals Inc
29/01/202416:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PCSAProcessa Pharmaceuticals Inc
27/01/202401:04GlobeNewswire Inc.Processa Pharmaceuticals Announces Pricing of $7.0 Million Public OfferingNASDAQ:PCSAProcessa Pharmaceuticals Inc
26/01/202400:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
26/01/202400:30GlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 DosesNASDAQ:PCSAProcessa Pharmaceuticals Inc
20/01/202400:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/01/202423:45GlobeNewswire Inc.Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast CancerNASDAQ:PCSAProcessa Pharmaceuticals Inc
19/01/202400:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
18/01/202423:45GlobeNewswire Inc.Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock SplitNASDAQ:PCSAProcessa Pharmaceuticals Inc
09/01/202408:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
03/01/202409:06GlobeNewswire Inc.Processa Pharmaceuticals to Present at the Biotech Showcase 2024NASDAQ:PCSAProcessa Pharmaceuticals Inc
30/12/202300:55Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PCSAProcessa Pharmaceuticals Inc
20/12/202301:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PCSAProcessa Pharmaceuticals Inc
20/12/202301:00GlobeNewswire Inc.Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
14/12/202301:00GlobeNewswire Inc.Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation CapecitabineNASDAQ:PCSAProcessa Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PCSA